v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Feb. 09, 2026
Mar. 31, 2026
Subsidiary, Sale of Stock [Line Items]    
Sale of units in public offering   2,250,000
Underwriters reimbursement   $ 2,156,250
Deferred underwriting fees   12,075,000
Over-Allotment Option [Member]    
Subsidiary, Sale of Stock [Line Items]    
Sale of units in public offering 2,250,000  
IPO [Member]    
Subsidiary, Sale of Stock [Line Items]    
Sale of units in public offering 17,250,000  
Gross proceeds from public offering $ 172,500,000 $ 3,450,000